Is Adaptimmune Therapeutics plc (ADAP) a Buy, Sell, or Hold?
NASDAQ : ADAP
Adaptimmune Therapeutics plc
$0.0485 USD
$0.0 (-3.0%)
- Volume
- 1.68M
- Average Volume
- 110.64M
- Market Capitalization
- $75.16M
- P/E Ratio
- -0.16
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.86
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.52
ADAP vs. The Competition
| Properties | ADAP | ANL | APLM | BLRX |
|---|---|---|---|---|
| Market Cap | $75.16M | $564.24M | $21.17M | $12.71M |
| Shares Outstanding | $1.55B | $53.08M | $1.1M | $4.35M |
| P/E Ratio | -0.16 | -6.56 | -2.54 | -1.37 |
| EPS | -0.3 | -1.61 | -25.98 | -0.05 |
| Day Low | 0.0425 | 9.07 | 17.2703 | 2.9 |
| Day high | 0.0599 | 10.705 | 19.65 | 2.98 |
| Year Low | 0.0202 | 0.879 | 3.659 | 2.15 |
| Year High | 0.86 | 17.25 | 42.12 | 4.75 |
| Average Price 50 | 0.10275 | 11.3514 | 16.21152 | 3.159 |
| Average Price 200 | 0.2588 | 6.8301 | 17.71395 | 3.0673 |
| Volume | 1.68M | 136.07K | 34210 | 2354 |
| Average Volume | - | - | - | - |